Xeris Forecasts $385m-$390m 2026 Revenue as Recorlev Expands and Xp-8121 Phase III Start Targets Year End
Earnings Call Insights: Xeris Biopharma (XERS) Q2 2026 Management View - Chairman & CEO John Shannon said, "The second quarter was another record-breaking quarter for Xeris" and reported that "Total revenue reached $92 million with net product revenue of $91 million,... pr